{"id":"W2200208573","doi":"10.1016/j.ahj.2015.12.009","title":"Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"British Microcirculation Society; Novartis; Novo Nordisk; Merck; Bayer; AstraZeneca","keywords":"Exenatide; Medicine; Glycemic; Clinical endpoint; Placebo; Myocardial infarction; Stroke (engine); Type 2 diabetes; Internal medicine; Semaglutide; Liraglutide; Randomized controlled trial; Diabetes mellitus; Insulin; Endocrinology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04673658,0.00441707,0.00498922,0.001594166,0.002137666,0.003897297,0.002883452,0.00483553,0.01479764],"category_scores_gemma":[0.03039664,0.003289585,0.002833645,0.001539763,0.004414428,0.002235311,0.001615595,0.006944561,0.005272246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001721102,"about_ca_system_score_gemma":0.006521106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009210114,"about_ca_topic_score_gemma":0.001529245,"domain_scores_codex":[0.9691617,0.02094066,0.002396954,0.00326781,0.002818926,0.00141394],"domain_scores_gemma":[0.9934149,0.002139969,0.001170933,0.001015985,0.0007706467,0.001487473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6648039,0.008892173,0.03312836,0.01615502,0.007569239,0.001871219,0.001627698,0.004580599,0.006265707,0.06817703,0.0583864,0.1285427],"study_design_scores_gemma":[0.6887293,0.0394776,0.04382101,0.006289317,0.008486421,0.001609753,0.0006763887,0.008037657,0.003268587,0.05693419,0.1419583,0.0007113644],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.1182716,0.0529111,0.05528625,0.03456652,0.01677568,0.6543772,0.02778876,0.0008032819,0.03921976],"genre_scores_gemma":[0.2888438,0.007983955,0.0572496,0.02490933,0.006294194,0.5984779,0.007176459,0.0001771877,0.008887604],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04673658,"threshold_uncertainty_score":0.2471696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05568336115756114,"score_gpt":0.2985380026289485,"score_spread":0.2428546414713873,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}